Carcinoid tumors of the stomach

Surgical Oncology

Volumn 12, Issue 2, 2003, Pages 153-172

  Modlin, Irvin M ^a   Lye, Kevin D ^a   Kidd, Mark ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinoid; ECL cell; Epidemiology; Gastrin; Metastases; Proliferation; Stomach

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ALPHA INTERFERON; AMINE; CHROMOGRANIN; CHROMOGRANIN A; CHROMOGRANIN B; CISPLATIN; ETOPOSIDE; GASTRIN; GLYCOPHORIN A; HISTAMINE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; OXYNTOMODULIN; PEPTIDE; PROTEIN P53; PROTON PUMP INHIBITOR; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE;

ARGYROPHILIA; ARTIFICIAL EMBOLISM; ATROPHIC GASTRITIS; BIOCHEMISTRY; BIOLOGY; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CARCINOID; CARCINOID SYNDROME; CELL PROLIFERATION; CELL SECRETION; CHROMOSOME 11Q; CHRONIC GASTRITIS; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; ENDOCRINE CELL; ENDOSCOPIC BIOPSY; GASTRINOMA; GASTROINTESTINAL ENDOSCOPY; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HYPERGASTRINEMIA; IMMUNOHISTOLOGY; LONG TERM EXPOSURE; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE SYSTEM; NEUROENDOCRINE TUMOR; NONHUMAN; PATHOLOGY; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; REGULATORY MECHANISM; REVIEW; RISK FACTOR; STEM CELL; STOMACH; STOMACH ACID; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH CANCER; STOMACH SECRETION; VAGOTOMY; ZOLLINGER ELLISON SYNDROME;

EID: 0142075701     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-7404(03)00034-3     Document Type: Review

References (110)

1. Modlin I., Tang L. The gastric enterochromaffin-like cell. an enigmatic cellular lesion Gastroenterology. 111:1996;783-810.
2. Gough D., Thompson G., Crotty T.et al. Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia. World Journal of Surgery. 18:1994;472-480.
3. Askanazy M. Zur Pathogenese der Magen-krebse und uber inhren gelegentlichen Ursprung aus angeboren epithelialen Keimen in der Magenwand. Deutsche Medizinische Wochenschrift. 49:1923;49-51.
4. Ahlman H., Kolby L., Lundell L.et al. Clinical Management of gastric carcinoid tumors. Digestion. 55:1994;77-85.
5. Gilligan C.J., Lawton G.P., Tang L.H., West A.B., Modlin I.M. Gastric carcinoid tumors. the biology and therapy of an enigmatic and controversial lesion American Journal of Gastroenterology. 90:1995;338-352.
6. Rindi G., Bordi C., Rappel S., La Rosa S., Stolte M., Solcia E. Gastric carcinoids and neuroendocrine carcinomas. pathogenesis, pathology and behavior World Journal of Surgery. 20:1996;168-172.
7. Modlin I.M., Lawton G.P., Tang L.H., Geibel J., Abraham R., Darr U. The Mastomys gastric carcinoid. aspects of ECL cell function Digestion. 55(Suppl 3):1994;31-37.
8. Arnold R. Medical treatment of metastasizing carcinoid tumors. World Journal of Surgery. 20:1996;203-207.
9. Modlin I.M., Lye K.D., Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 97(4):2003;934-959.
10. Haque S., Modlin I., West A. Multiple glomus tumors of the stomach with intravascular spread. American Journal of Surgical Pathology. 16:1992;291-299.
11. Sarlomo-Rikala M., Miettinen M. Gastric schwannoma. a clinicopathological analysis of six cases Histopathology. 27:1995;355-360.
12. Petersen J., Ferguson D. Gastrointestinal neurofibromatosis. Journal of Clinical Gastroenterology. 6:1984;529-534.
13. Bees N., Ng C., Dick-Mireaux C., Kiely E. Gastric malignant schwannoma in a child. British Journal of Radiology. 70:1997;952-955.
14. Snow P., Lennard-Jones J., Curzon G., Stacey R. Humoral effects of metastasizing carcinoid tumors. Lancet. 269(II):1955;1004-1009.
15. Sandler M., Snow P. An atypical carcinoid tumor secreting 5-hydroxytryptophan. Lancet. 1:1958;137-139.
16. Wilander E., el-Salhy M., Pitkanen P. Histopathology of gastric carcinoids. a survey of 42 cases Histopathology. 8:1984;183-193.
17. DeSchryver-Kecskemeti K., Clouse R., Kraus F. Surgical pathology of gastric and duodenal neuroendocrine tumors masquerading as common polyps. Seminars Diagnostic Pathology. 1:1984;5-12.
18. Sjoblom S. Clinical presentation and prognosis of gastrointestinal carcinoid tumours. Scandinavian Journal of Gastroenterology. 23:1988;779-787.
19. Purcell R., Singh I., Lewis E.et al. Gastric carcinoid presenting with massive upper gastrointestinal bleeding. New York State Journal of Medicine. 88:1988;80-81.
20. Green S., Drury J., McCallion J.et al. Carcinoid tumour presenting as recurrent gastric outlet obstruction. a case of long-term survival Scottish Medical Journal. 32:1987;54-55.
21. Rodriguez G., Villamizar R. Carcinoid tumor with skin metastasis. American Journal of Dermatopathology. 14:1992;263-269.
22. 2 receptors in human vasculature New England Journal of Medicine. 300:1979;236-238.
23. Ahlman H., Dahlstrom A., Enerback L.et al. Two cases of gastric carcinoids. diagnosis and therapeutic aspects World Journal of Surgery. 12:1988;356-361.
24. Ahlman H., Wangberg B., Nilsson O.et al. Aspects on diagnosis and treatment of the foregut carcinoid syndrome. Scandinavian Journal of Gastroenterology. 27:1992;459-471.
25. Giordano J. Gastric carcinoid syndrome diagnosed by endoscopy. American Journal of Gastroenterology. 76:1981;41-43.
26. Johansson H., Wilander E. A clinical study of 30 gastric carcinoids. Upsala Journal of Medical Sciences. 87:1982;135-142.
27. Rindi G., Luinetti O., Cornaggia M., Capella C., Solcia E. Three subtypes of argyrophillic carcinoid and the gastric neuroendocrine carcinoma. A clinicopathological study. Gastroenterology. 104:1993;994-1006.
28. Nosaka T., Habu H., Endo M., Okayasu I. Multiple carcinoid tumors of the stomach with hypergastrinemia. American Journal of Gastroenterology. 87:1992;766-770.
29. Bordi C., Azzoni C., Feraro G.et al. Sampling strategies for analysis of enterochromaffin-like cell changes in Zollinger-Ellison syndrome. American Journal of Clinical Pathology. 114:2000;419-425.
30. Nakamura S., Lida M., Yao T.et al. Endoscopic features of gastric carcinoids. Gastrointestinal Endoscopy. 37:1991;535-538.
31. Giovannini M., Seitz J., Thomas P.et al. Electronic sectorial ultrasound endoscopy in benign and malignant tumoral pathology of the stomach. results in 30 patients Gastroenterologica Cliniquecet Biologique. 17:1993;26-32.
32. Naitoh H., Kumashiro R., Teshima K.et al. A minute, solitary carcinoid of the stomach with a lymph node metastasis. a case report Gan No Rinsho. 34:1988;908-913.
33. Kuyer P., Rosenbusch G., Yap S., de Boer H. The variable picture of gastric carcinoid. Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. 146:1987;184-188.
34. Picus D., Glazer H., Levitt R.et al. Computed tomography of abdominal carcinoid tumors. American Journal of Radiology. 143:1984;581-584.
35. Hurst R., Modlin I. Use of radiolabeled somatostatin analogs in the identification and treatment of somatostatin receptor-bearing tumors. Digestion. 54:1993;88-91.
36. Godwin J. Carcinoid tumors. An analysis of 2837 cases. Cancer. 36:1975;560-569.
37. Hirschowitz B., Griffith J., Pellegrin D., Cummings O. Rapid regression of enterochromaffin-like cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology. 102:1992;1409-1418.
38. Sjoblom S., Sipponen P., Miettinen M., Karonen S., Jarvinen H. Gastroscopic screening for gastric carcinoids and carcinoma in pernicious anemia. Endoscopy. 20:1988;52-56.
39. Borch K., Renvall H., Liedberg G. Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology. 88:1985;638-648.
40. Borch K. Epidemiologic, clinicopathologic and economic aspects of gastroscopic screening of patients with pernicious anemia. Scandinavian Journal of Gastroenterology. 21:1986;21-30.
41. Lehtola J., Karrttunen T., Krekela I., Niemela S., Rasanen O. Gastric carcinoids with minimal or no macroscopic lesions in patients with pernicious anemia. Hepato-Gastroenterology. 32:1985;72-76.
42. Hakanson R., Owman C., Sporrong B., Sundler F. Electron microscopic identification of the histamine-storing argyrophil (enterochromaffin-like) cells in the rat stomach. Zeitschrift fuer Zellforschung. 122:1971;460-466.
43. Capella C., Vassallo G., Solcia E. Light and electron microscopic identification of the histamine-storing agyrophil (ECL) cell in murine stomach and of its equivalent in other mammals. Zeibschrift fuer Zellforschung. 118:1971;68-70.
44. Sundler F., Hakanson R. Gastric endocrine cell typing at the light microscopic level. Hakanson R., Sundler F. The stomach as an endocrine organ. 1991;Elsevier, Amsterdam.
45. Solcia E., Fiocca R., Sessa F.et al. Morphology and natural history of gastric endocrine tumours. Hakanson R., Sundler F. The stomach as an endocrine organ. 1991;473-498 Elsevier, Amsterdam.
46. Hakanson R., Sundler F. Proposed mechanism of gastric carcinoids. the gastrin hypothesis European Journal of Clinical Investigation. 20:1990;S65-S71.
47. Borch K., Renvall H., Liedberg G., Andersen B.N. Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa. Scandinavian Journal of Gastroenterology. 21(3):1986;357-363.
48. Cattan D., Roucayrol A.M., Launay J.M., Callebert J., Charasz N., Nurit Y., Belaiche J., Kalifat R. Circulating gastrin, endocrine cells, histamine content, and histidine decarboxylase activity in atrophic gastritis. Gastroenterology. 97(3):1989;586-596.
49. Laüffer J., Modlin I., Hinoue T.et al. Pituitary adenylate cyclase-activating polypeptide modulates gastric enterochromaffin-like cell proliferation in rats. Gastroenterology. 116:1999;623-635.
50. Hakanson R., Axelson J., Tielemens Y., Johansson A-.G., Willems G., Sundler F. Unilateral vagal denervation suppresses omeprazole-induced trophic effects on the denervated side of the rat stomach. Scandinavian Journal of Gastroenterology. 27:1992;65-70.
51. Lehy T., Mignon M., Cadiot G.et al. Gastric endocrine cell behavior in Zollinger-Ellison patients upon long term potent antisecretory treatment. Gastroenterology. 96:1989;1029-1040.
52. Waldum H., Aase S., Kvetnoi I.et al. Neuroendocrine differentiation in human gastric carcinoma. Cancer. 83:1998;435-444.
53. Saha S, Hoda S, Godfrey R. Vagotomy. In: Modlin I, editor. Lester Dragstedt Centenary Symposium. New Haven. Yale Journal of Biology and Medicine 1994;67:153-8.
54. Solcia E., Bordi C., Creutzfeldt W., Dayal Y. Histopathological classification of non-antral gastric endocrine growths in man. Digestion. 41:1988;185-200.
55. Solcia E., Capella C., Fiocca R., Rindi G., Rosai J. Gastric argyrophil carcinoidosis in patients with ZE syndrome due to Type I MEN. a newly diagnosed association American Journal of Surgical Pathology. 14:1990;503-513.
56. Solcia E., Fiocca R., Villani L., Luinetta O., Capella C. Hyperplastic, dysplastic and neoplastic enterochromaffin-like cell proliferations of the gastric mucosa. Classification and histogenesis. American Journal of Surgical Pathology. 19(Suppl 1):1995;S1-S7.
57. Rappel S., Altendorf-Hofmann A., Stoite M. Prognosis of gastric carcinoid. Digestion. 56:1995;455-462.
58. Bordi C., Yu J., Baggi M.et al. Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases. Cancer. 67:1991;663-672.
59. Bordi C., D'Adda T., Azzoni C., Ferraro G. Pathogenesis of ECL cell tumors in humans. Yale Journal of Biology Medicine. 71:1998;273-284.
60. Arnold R, Koppel G, Rothmund M. Carcinoid tumors. International Symposium on Pathology, Clinical Aspects and Therapy. 13-17 January 1994, Munich, Germany. Digestion 1994;55:1(Suppl 3).
61. Jensen R. Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. Journal of Internal Medicine. 243:1998;477-488.
62. Feurle G. Argyrophil cell hyperplasia and a carcinoid tumor in the stomach of a patient with sporadic Zollinger-Ellison syndrome. Gut. 35:1994;275-277.
63. Lehy T., Cadiot M., Ruszniewski P., Bonfils S. Influence of multiple endocrine neoplasia type I on gastric endocrine cell in patients with Zollinger-Ellison syndrome. Gut. 33:1992;1275-1279.
64. Larsson C., Skogseid B., Oberg K., Nakamura Y., Nordenskjold M. Mulitple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature. 332:1988;85-87.
65. Debelenko L., Emmert-Buck M., Zhuang Z.et al. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids. Gastroenterology. 113:1997;773-781.
66. D'Adda T., Keller G., Bordi C., Hofler H. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome. Laboratory Investigation. 79:1999;671-677.
67. Gortz B., Roth J., Krahenmann A.et al. Mutations and allelic deletions of the MEN1 gene are associated with a subset of pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms. American Journal of Pathology. 154:1999;429-436.
68. Gibril F., Reynolds J., Lubensky I.et al. Ability of somatostatin receptor scintigraphy to identify patients with gastric carcinoids. a prospective study Journal of Nuclear Medicine. 41:2000;1646-1656.
69. Portel-Gomes G., Grimelius L., Johansson H., Wilander E., Stridsberg M. Chromogranin A in human neuroendocrine tumors. an immunohistochemical study with region-specific antibodies American Journal of Surgical Pathology. 25:2001;1261-1267.
70. Borch K., Stridsberg M., Burman P., Rehfeld J. Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis. Scandinavian Journal of Gastroenterology. 32:1997;198-202.
71. Granberg D., Wilander E., Stridsberg M., Granerus G., Skogseid B., Oberg K. Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids. Gut. 43(2):1998;223-228.
72. Thomas R.M., Baybick J.H., Elsayed A.M., Sobin L.H. Gastric carcinoids. An immunohistochemical and clinicopathologic study of 104 patients. Cancer. 73(8):1994;2053-2058.
73. Azzoni C., Doglioni C., Viale G., Delle Fave G., De Boni M., Caruana P., Ferraro G., Bordi C. Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids. American Journal of Surgical Pathology. 20(4):1996;433-441.
74. Goebel S., Serrano J., Yu F., Gibril F., Venzon D., Jensen R. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas. Cancer. 85:1999;1470-1483.
75. Granberg D., Wilander E., Stridsberg M., Granerus G., Skogseid B., Oberg K. Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids. Gut. 43:1998;223-228.
76. Bordi C., D'Adda T., Azzoni C., Ferraro G. Pathogenesis of ECL cell tumors in humans. Yale Journal of Biology and Medicine. 71:1998;273-284.
77. Weiber H., Borch K., Sundler F., Fernlund P. b-microseminoprotein in gastric carcinoids. a marker of tumor progression Digestion. 60:1999;440-448.
78. Smith A., Watson S., Caplin M.et al. Gastric carcinoid expresses the gastrin autocrine pathway. British Journal of Surgery. 85:1998;1285-1289.
79. Reinecke P., Borchard F. Pattern of gastric endocrine cells in microcarcinoidosis-an immunohistochemical study of 14 gastric biopsies. Virchows Archiv. 428:1996;237-241.
80. Thomas R.M., Baybick J.H., Elsayed A.M., Sobin L.H. Gastric carcinoids. an immunohistochemical and clinicopathologic study of 104 patients Cancer. 73:1994;2053-2058.
81. Rindi G., Azzoni C., La Rosa S.et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach. prognostic evaluation by pathological analysis Gastroenterology. 116:1999;532-542.
82. Debelenko L., Emmert-Buck M., Zhuang Z.et al. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids. Gastroenterology. 113:1997;773-781.
83. Krenning E., Kooij P., Pauwels S.et al. Somatostatin receptor scintigraphy and radionuclide therapy. Digestion. 57:1996;57-61.
84. Stolte M. Clinical consequences of the endoscopic diagnosis of gastric polyps. Endoscopy. 27(1):1995;32-37.
85. Papa A., Cammarota G., Tursi A., Montalto M., Cuoco L., Certo M., Fedeli G., Gasbarrini G. Histologic types and surveillance of gastric polyps: a seven year clinico-pathological study. Hepato-Gastroenterology. 45(20):1998;579-582.
86. Borch K., Renvall H., Kullman E., Wilander E. Gastric carcinoid associated with the syndrome of hypergastrinemic atrophic gastritis. A prospective analysis of 11 cases. American Journal of Surgical Pathology. 11(6):1987;435-444.
87. Ahlman H., Kolby L., Lundell L., Olbe L., Wangberg B., Granerus G., Grimelius L., Nilsson O. Department of Surgery, Sahlgrens Hospital, Goteborg, Sweden. Clinical management of gastric carcinoid tumors. Digestion. 55(Suppl 3):1994;77-85.
88. Higham A.D., Dimaline R., Varro A., Attwood S., Armstrong G., Dockray G.J., Thompson D.G. Octreotide suppression test predicts beneficial outcome from antrectomy in a patient with gastric carcinoid tumor. Gastroenterology. 114(4):1998;817-822.
89. Higham A., Dimaline R., Varro A.et al. Octreotide suppression test predicts beneficial outcome from antrectomy in a patient with gastric carcinoid tumor. Gastroenterology. 114:1998;817-822.
90. Bordi C. Endocrine tumors of the stomach. Pathology Research and Practice. 191:1995;373-380.
91. Tang L., Luque E., Efstathiou J.et al. Gastrin receptor expression and function during rapid transformation of the enterochromaffin-like cells in an African rodent. Regulatory Peptides. 72:1997;9-18.
92. Kumashiro R., Naitoh H., Teshima K., Sakai T., Inutsuka S. Minute gastric carcinoid tumor with regional lymph node metastasis. International Surgery. 74:1989;1013-1014.
93. De Vries E., Kema I., Sloof M.et al. Recent developments in diagnosis and treatment of metastatic carcinoid tumors. Scandinavian Journal of Gastroenterology. 200(Suppl):1993;87-93.
94. 3]-octreotide. the Rotterdam experience with more than 1000 patients European Journal of Nuclear Medicine. 20:1993;716-731.
95. Oberg K. Chemotherapy and biotherapy in the treatment of neuroendocrine tumors. Annals of Oncology. 1(Suppl 2):2001;S111-114.
96. Davies M., O'Dowd G., McEntee G., Hennessy T. Primary gastric carcinoids. a view on management British Journal of Surgery. 77:1990;1013-1014.
97. Oberg K., Funa K., Alm G. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome. New England Journal of Medicine. 309:1983;129-132.
98. Jensen R., Norton J. Carcinoid tumors and the carcinoid syndrome. DeVita V., HeUman S., Rosenberg S. Cancer: principles and practice of oncology. 1997;1704-1723 Lippincott-Raven Publishers, Philadelphia.
99. Annibale B., Delle Fave G., Azzoni C.et al. Three months of octreotide treatment decreases gastric acid secretion and argyrophil cell density in patients with Zollinger-Ellison syndrome and antral G-cell hyperfunction. Alimentary Pharmacology and Therapeutics. 8:1994;95-104.
100. Borin J., Tang L., Kidd M.et al. Somatostatin receptor (SSTR) regulation of gastric Enterochromaffin-like cell transformation to gastric carcinoid. Surgery. 120:1996;1026-1032.
101. Tomassetti P., Migliori M., Caletti G., Fusaroli P., Corinaldesi R., Gullo L. Treatment of type II gastric carcinoid tumors with somatostatin analogues. New England Journal of Medicine. 343:2000;551-554.
102. Tang L., Modlin I., Lawton G., Kidd M., Chinnery R. The role of TGF-alpha in the Enterochromaffin-like (ECL) cell tumor autonomy in an African Rodent Mastomys. Gastroenterology. 111:1996;1212-1223.
103. Modlin I., Sandor A., Tang L., Kidd M., Zelterman D. A 40 year analysis of 265 gastric carcinoids. American Journal of Gastroenterology. 92:1997;633-638.
104. Modlin I., Sandor A. An analysis of 8,305 cases of carcinoid tumor. Cancer. 79:1997;813-829.
105. Konturek S.J., Konturek P.C., Bielanski W.et al. Case presentation of gastrinoma combined with gastric carcinoid with the longest survival record-Zollinger Ellison syndrome. pathophysiology, diagnosis and therapy Medical Science Monitor. 8:2002;CS43-CS59.
106. Meko J., Norton J. Management of patients with Zollinger-Ellison syndrome. Annual Review of Medicine. 46:1995;395-411.
107. Lamberts R., Creutzfeldt W., Stockman F., Jacubaschke U., Maas S., Brunner G. Long term omeprazole treatment in man. effects on gastric endocrine cell populations Digestion. 39:1988;126-135.
108. Lamberts R., Creutzfeldt W., Struber H.G., Brunner G., Solcia E. Long-term omeprazole therapy in peptic ulcer disease. gastrin, endocrine cell growth, and gastritis Gastroenterology. 104:1993;1356-1370.
109. Solcia E., Rindi G., Havu N.et al. Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole. Scandinavian Journal of Gastroenterology. 166(Suppl):1989;129-137.
110. Solcia E., Villani L., Luinetti O.et al. Proton pump inhibitors, enterochromaffin-like cell growth and Helicobacter pylori gastritis. Alimentary Pharmacology and Therapeutics. 1:1993;25-28.